Literature DB >> 19647363

Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: their inhibition by curcumin.

Ji Hye Seo1, Kang Jin Jeong, Woo Jin Oh, Hae Jeong Sul, Jang Sihn Sohn, Yong Kee Kim, Do Yeun Cho, Jae Ku Kang, Chang Gyo Park, Hoi Young Lee.   

Abstract

Lysophosphatidic acid (LPA) is a biolipid that stimulates tumor cell invasion and metastasis. In this report, we determined the role of signal transducers and activators of transcription 3 (STAT3) and the effect of a chemopreventive agent, curcumin, on LPA-induced ovarian cancer cell motility. LPA phosphorylated STAT3 in a dose-dependent manner. Treatment of cells with a JAK/STAT inhibitor, AG490, inhibited LPA-induced cell motility. In contrast, transfection of a constitutively active form of STAT3 induced ovarian cancer cell motility. LPA also stimulated interleukin (IL)-6 and IL-8 secretion, which results in STAT3 phosphorylation. Treatment of the cells with curcumin inhibited LPA-induced IL-6 and IL-8 secretion and STAT3 phosphorylation, leading to blocked ovarian cancer cell motility. Collectively, the present study shows the critical role of STAT3 in ovarian cancer cell motility and that this process can be prevented by curcumin. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647363     DOI: 10.1016/j.canlet.2009.06.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  39 in total

1.  hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness.

Authors:  M J Choi; K H Cho; S Lee; Y J Bae; K J Jeong; S Y Rha; E J Choi; J H Park; J M Kim; J-S Lee; G B Mills; H Y Lee
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

2.  Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.

Authors:  Ji Hee Ha; Jeremy D Ward; Rangasudhagar Radhakrishnan; Muralidharan Jayaraman; Yong Sang Song; Danny N Dhanasekaran
Journal:  Oncotarget       Date:  2016-06-21

Review 3.  Therapeutic potential of curcumin in digestive diseases.

Authors:  Pietro Dulbecco; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

4.  Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment.

Authors:  Charlotta D Mock; Brian C Jordan; Chelliah Selvam
Journal:  RSC Adv       Date:  2015-09-02       Impact factor: 3.361

5.  Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice.

Authors:  Ya-Lan Dong; Xue-Yun Duan; Yu-Jin Liu; Heng Fan; Meng Xu; Qian-Yun Chen; Zhen Nan; Hui Wu; Shuang-Jiao Deng
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

6.  Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.

Authors:  Jin Chen; Feng-Ling Wang; Wei-Dong Chen
Journal:  Mol Biol Rep       Date:  2014-03-07       Impact factor: 2.316

7.  Deletion of Na+/H+ exchanger regulatory factor 2 represses colon cancer progress by suppression of Stat3 and CD24.

Authors:  Michihiro Yoshida; Luqing Zhao; Gevorg Grigoryan; Hyunsuk Shim; Peijian He; C Chris Yun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-02-11       Impact factor: 4.052

8.  Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: differential cytotoxicity in healthy and cancer cells.

Authors:  Karuppaiyah Selvendiran; Shabnam Ahmed; Alex Dayton; M Lakshmi Kuppusamy; Mia Tazi; Anna Bratasz; Liyue Tong; Brian K Rivera; Tamás Kálai; Kálmán Hideg; Periannan Kuppusamy
Journal:  Free Radic Biol Med       Date:  2010-02-12       Impact factor: 7.376

Review 9.  Anti-ovarian cancer potential of phytocompound and extract from South African medicinal plants and their role in the development of chemotherapeutic agents.

Authors:  Chella Perumal Palanisamy; Bo Cui; Hongxia Zhang; Mani Panagal; Sivagurunathan Paramasivam; Uma Chinnaiyan; Selvaraj Jeyaraman; Karthigeyan Murugesan; Mauricio Rostagno; Vijayakumar Sekar; Srinivasa Prabhu Natarajan
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

10.  Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model.

Authors:  Cyril Touboul; Raphael Lis; Halema Al Farsi; Christophe M Raynaud; Mohamed Warfa; Hamda Althawadi; Eliane Mery; Massoud Mirshahi; Arash Rafii
Journal:  J Transl Med       Date:  2013-01-31       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.